Clinical Trial Update: Cancer Biology of Retinoblastoma

View source ↗

Summary

The Stanford University-sponsored clinical trial on the cancer biology of retinoblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Snippet

Sponsor: Stanford University | Conditions: Retinoblastoma | Status: TERMINATED